181 related articles for article (PubMed ID: 21397497)
1. Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
Zheng G; Zhang Z; Dowell C; Wala E; Dwoskin LP; Holtman JR; McIntosh JM; Crooks PA
Bioorg Med Chem Lett; 2011 Apr; 21(8):2476-9. PubMed ID: 21397497
[TBL] [Abstract][Full Text] [Related]
2. The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.
Holtman JR; Dwoskin LP; Dowell C; Wala EP; Zhang Z; Crooks PA; McIntosh JM
Eur J Pharmacol; 2011 Nov; 670(2-3):500-8. PubMed ID: 21944926
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
4. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
5. Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.
Zheng G; Zhang Z; Pivavarchyk M; Deaciuc AG; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2007 Dec; 17(24):6734-8. PubMed ID: 18029180
[TBL] [Abstract][Full Text] [Related]
6. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
Wala EP; Crooks PA; McIntosh JM; Holtman JR
Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel alpha7 nicotinic receptor antagonists.
Peng Y; Zhang Q; Snyder GL; Zhu H; Yao W; Tomesch J; Papke RL; O'Callaghan JP; Welsh WJ; Wennogle LP
Bioorg Med Chem Lett; 2010 Aug; 20(16):4825-30. PubMed ID: 20638843
[TBL] [Abstract][Full Text] [Related]
8. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
9. Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
Zheng G; Sumithran SP; Deaciuc AG; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2007 Dec; 17(24):6701-6. PubMed ID: 17977723
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979
[TBL] [Abstract][Full Text] [Related]
11. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
12. Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.
Vincler M; McIntosh JM
Expert Opin Ther Targets; 2007 Jul; 11(7):891-7. PubMed ID: 17614758
[TBL] [Abstract][Full Text] [Related]
13. Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4].
Xu P; Zhang P; Zhu X; Wu Y; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2023 Jul; 66(14):10092-10107. PubMed ID: 37464764
[TBL] [Abstract][Full Text] [Related]
14. Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.
Zhang Z; Zheng G; Pivavarchyk M; Deaciuc AG; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2011 Jan; 21(1):88-91. PubMed ID: 21147530
[TBL] [Abstract][Full Text] [Related]
15. Dual Antagonism of α9α10 nAChR and GABA
Li X; Tae HS; Chen S; Yousuf A; Huang L; Zhang J; Jiang T; Adams DJ; Yu R
J Med Chem; 2024 Jan; 67(2):971-987. PubMed ID: 38217860
[TBL] [Abstract][Full Text] [Related]
16. New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidates.
Silva NM; Tributino JL; Miranda AL; Barreiro EJ; Fraga CA
Eur J Med Chem; 2002 Feb; 37(2):163-70. PubMed ID: 11858848
[TBL] [Abstract][Full Text] [Related]
17. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
20. Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.
Zhang Z; Zheng G; Pivavarchyk M; Deaciuc AG; Dwoskin LP; Crooks PA
Bioorg Med Chem Lett; 2008 Nov; 18(21):5753-7. PubMed ID: 18851914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
